Department of Thoracic and Cardiovascular Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
J Thorac Oncol. 2011 Aug;6(8):1304-12. doi: 10.1097/JTO.0b013e3182208e3f.
Extrapleural pneumonectomy has been well defined; however, surgeons vary regarding the surgical extent and goals of "pleurectomy/decortication" (P/D). We explored mesothelioma surgeons' concepts of P/D with the aim of unifying surgical nomenclature.
A web-based survey was administered to surgeons who operated on malignant pleural mesothelioma (MPM) for diagnosis, staging, palliation, or cytoreduction. One hundred thirty surgeons from 59 medical centers were included. Surgeons who did not perform surgery for MPM within the last year were excluded.
There were 62 (48%) respondents from 39 medical centers in 14 countries. The mean number of patients with MPM seen annually at each medical center was 46, and the mean annual number of cytoreductive procedures performed per surgeon was 8. Most (88%) agreed that the goal of cytoreductive surgery should be macroscopic complete resection of tumor. P/D was defined as resection of parietal and visceral pleura with the aim of achieving macroscopic complete resection by 72% of respondents. If the diaphragm or pericardium required resection, 64% preferred the term "radical P/D," whereas "P/D" (40%) or "total pleurectomy" (39%) was preferred if these structures were not removed. Most surgeons believed that extrapleural pneumonectomy (90%) or "radical P/D" (68%) could provide adequate cytoreduction, whereas only 23% thought that P/D could.
There was significant variation regarding surgical nomenclature for procedures for MPM. The International Staging Committee of the International Association for the Study of Lung Cancer and the International Mesothelioma Interest Group recommend that P/D should aim to remove all macroscopic tumor involving the parietal and visceral pleura and should be termed "extended" P/D when the diaphragm or pericardium is resected.
经胸膜外全肺切除术已经得到了很好的定义;然而,外科医生在“胸膜切除术/剥脱术”(P/D)的手术范围和目标上存在差异。我们探讨了间皮瘤外科医生对 P/D 的概念,旨在统一手术命名法。
我们向诊断、分期、姑息治疗或细胞减灭术的恶性胸膜间皮瘤(MPM)外科医生进行了一项基于网络的调查。共有来自 59 个医疗中心的 130 名外科医生参与了调查。过去一年未行 MPM 手术的外科医生被排除在外。
来自 14 个国家的 59 个医疗中心的 62 名(48%)外科医生做出了回应。每个医疗中心每年治疗的 MPM 患者数量的平均值为 46 例,每位外科医生每年进行的细胞减灭术数量的平均值为 8 例。大多数(88%)人认为,细胞减灭术的目标应该是肿瘤的大体完全切除。72%的受访者将 P/D 定义为切除壁层和脏层胸膜,旨在通过手术达到大体完全切除。如果需要切除膈肌或心包,64%的人更喜欢使用“根治性 P/D”这一术语,而如果不切除这些结构,则更喜欢使用“P/D”(40%)或“全胸膜切除术”(39%)。大多数外科医生认为,经胸膜外全肺切除术(90%)或“根治性 P/D”(68%)可以提供足够的细胞减灭,但只有 23%的人认为 P/D 可以。
针对 MPM 的手术命名法存在显著差异。国际肺癌研究协会的国际分期委员会和国际间皮瘤兴趣小组建议,P/D 应旨在切除累及壁层和脏层胸膜的所有大体肿瘤,如果切除膈肌或心包,则应将其称为“扩展”P/D。